ID: ALA441077

Max Phase: Preclinical

Molecular Formula: C36H34N2O4Si

Molecular Weight: 586.76

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

Standard InChI:  InChI=1S/C36H34N2O4Si/c1-5-36(41)28-20-30-31-26(21-38(30)33(39)27(28)22-42-34(36)40)32(25-18-12-13-19-29(25)37-31)43(35(2,3)4,23-14-8-6-9-15-23)24-16-10-7-11-17-24/h6-20,41H,5,21-22H2,1-4H3/t36-/m0/s1

Standard InChI Key:  SLBNNQKQBBDRHD-BHVANESWSA-N

Associated Targets(Human)

HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
833K (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DC3F (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 586.76Molecular Weight (Monoisotopic): 586.2288AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Josien H, Bom D, Curran DP, Zheng Y, Chou T.  (1997)  7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents,  (24): [10.1016/S0960-894X(97)10181-0]

Source